DeepMed Research

Eye & ENT Hospital of Fudan University

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Efficacy of Hearing-aid Treatment for Patients With Tinnitus and Co-existing Hearing Loss

Not Applicable

Conditions: Tinnitus, Subjective
Hearing Loss, High-Frequency

Interventions: Device: Hearing aids

First Posted Date: 2022-04-25

Last Posted Date: 2022-04-25

Lead Sponsor: Eye & ENT Hospital of Fudan University

Target Recruit Count: 62

Registration Number: NCT05343026

An Observational Study of Clinical Treatments for Patients With Oropharyngeal Carcinoma

Recruiting

Conditions: Oropharynx Carcinoma

Interventions: Procedure: Surgery for early-stage OPC
Procedure: Neoadjuvant treatment for advanced OPC
Radiation: CRT for advanced OPC
Radiation: RT for early-stage OPC
Other: Surgery for advanced OPC

First Posted Date: 2022-04-22

Last Posted Date: 2022-04-22

Lead Sponsor: Eye & ENT Hospital of Fudan University

Target Recruit Count: 200

Registration Number: NCT05341479

Locations: 🇨🇳
Department of Otorhinolaryngology, Eye & ENT Hospital, Shanghai, Shanghai, China

Comparison of the Sedation Effect of Esketamine and Sevoflurane for Pediatric Ophthalmological Procedure

Not Applicable

Completed

Conditions: Adverse Event

Interventions: Drug: Esketamine
Drug: Sevoflurane

First Posted Date: 2022-04-11

Last Posted Date: 2024-03-26

Lead Sponsor: Eye & ENT Hospital of Fudan University

Target Recruit Count: 116

Registration Number: NCT05321160

Locations: 🇨🇳
Anesthesiology Department of Affiliated Eye and ENT Hospital, Fudan University, Shanghai, Shanghai, China

Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN

Phase 2

Recruiting

Conditions: Head and Neck Neoplasms
Recurrent Disease
Metastatic Cancer

Interventions: Drug: Penpulimab combined with cetuximab

First Posted Date: 2022-03-02

Last Posted Date: 2023-10-18

Lead Sponsor: Eye & ENT Hospital of Fudan University

Target Recruit Count: 48

Registration Number: NCT05260671

Locations: 🇨🇳
Department of radiotherapy,The First Bethune Hospital of Jilin University, Changchun, Jilin, China
🇨🇳
Department of Radiotherapy, Eye & ENT Hospital of Fudan University, Shanghai, China

Tirelizumab Plus Surgery vs Surgery Alone for Recurrent Nasopharyngeal Carcinoma

Phase 2

Not yet recruiting

Conditions: Nasopharyngeal Carcinoma

Interventions: Drug: Tirelizumab
Procedure: salvage surgery

First Posted Date: 2021-10-25

Last Posted Date: 2021-10-25

Lead Sponsor: Eye & ENT Hospital of Fudan University

Target Recruit Count: 80

Registration Number: NCT05092217

Nimotuzumab Combined With Radiotherapy in High-risk Patients With HNSCC Not Suitable for Cisplatin After Surgery

Phase 2

Not yet recruiting

Conditions: Head and Neck Squamous Cell Carcinoma

Interventions: Drug: Nimotuzumab

First Posted Date: 2021-08-27

Last Posted Date: 2021-08-27

Lead Sponsor: Eye & ENT Hospital of Fudan University

Target Recruit Count: 95

Registration Number: NCT05024019

Locations: 🇨🇳
Ningbo Medical Center Lihuili Hospital, Ningbo, China
🇨🇳
Zhejiang Cancer Hospital, Hangzhou, China
🇨🇳
Shanghai General Hospital/First People's Hospital Affiliated with Shanghai Jiao Tong University, Shanghai, China

and more 3 locations

Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma

Phase 2

Recruiting

Conditions: Recurrent Nasopharyngeal Carcinoma

Interventions: Drug: Camrelizumab
Drug: Chemotherapy
Procedure: endoscopic surgery

First Posted Date: 2021-08-18

Last Posted Date: 2024-03-06

Lead Sponsor: Eye & ENT Hospital of Fudan University

Target Recruit Count: 100

Registration Number: NCT05011227

Locations: 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China
🇨🇳
Fujian Provincial Hospital, Fuzhou, Fujian, China
🇨🇳
Shenzhen Second People's Hospital, Shenzhen, Guangdong, China

and more 4 locations

Comparison of Sedation by Esketamine and Sevoflurane

Phase 4

Conditions: Sevoflurane

Interventions: Drug: Sevoflurane
Drug: Esketamine

First Posted Date: 2021-08-18

Last Posted Date: 2022-04-05

Lead Sponsor: Eye & ENT Hospital of Fudan University

Target Recruit Count: 60

Registration Number: NCT05011214

Locations: 🇨🇳
Anesthesiology Department of Affiliated Eye and ENT Hospital, Fudan University, Shanghai, Shanghai, China

Single Arm Study of Induction Chemoradiotherapy Combined With Surgery in the Treatment of Locally Advanced SNMM

Early Phase 1

Recruiting

Conditions: Sinonasal Melanoma
Mucosal Melanoma

Interventions: Procedure: endoscopic surgery
Radiation: intensity-modulated radiation therapy or volume of rotating intensity-modulated radiotherapy or Proton or heavy ion radiation therapy
Drug: Chemotherapy drug

First Posted Date: 2021-08-17

Last Posted Date: 2021-08-17

Lead Sponsor: Eye & ENT Hospital of Fudan University

Target Recruit Count: 28

Registration Number: NCT05009446

Locations: 🇨🇳
Eye& ENT Hospital, Fudan University, Shanghai, Shanghai, China

Clinical Treatments in Specialized Disease of Laryngeal Carcinoma (LC) and Hypopharyngeal Carcinoma (HPC)

Conditions: Pyriform Sinus Carcinoma
Postcricoid Carcinoma
Supraglottic Carcinoma
Subglottic Carcinoma
Glottic Carcinoma
Posterior Pharyngeal Wall Carcinoma

Interventions: Procedure: routines

First Posted Date: 2021-06-01

Last Posted Date: 2021-06-01

Lead Sponsor: Eye & ENT Hospital of Fudan University

Target Recruit Count: 1000

Registration Number: NCT04908696

Locations: 🇨🇳
Lei Tao, Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy